| Why amorphous drugs? M Rams-Baron, R Jachowicz, E Boldyreva, D Zhou, W Jamroz, M Paluch, ... Amorphous Drugs: Benefits and Challenges, 1-7, 2018 | 79 | 2018 |
| Design, Synthesis and In Vitro Activity of Anticancer Styrylquinolines. The p53 Independent Mechanism of Action A Mrozek-Wilczkiewicz, E Spaczynska, K Malarz, W Cieslik, ... PLoS One 10 (11), e0142678, 2015 | 57 | 2015 |
| Molecular dynamics, recrystallization behavior, and water solubility of the amorphous anticancer agent bicalutamide and its polyvinylpyrrolidone mixtures J Szczurek, M Rams-Baron, J Knapik-Kowalczuk, A Antosik, J Szafraniec, ... Molecular pharmaceutics 14 (4), 1071-1081, 2017 | 51 | 2017 |
| Co-Stabilization of amorphous pharmaceuticals—the case of nifedipine and nimodipine J Knapik-Kowalczuk, W Tu, K Chmiel, M Rams-Baron, M Paluch Molecular Pharmaceutics 15 (6), 2455-2465, 2018 | 44 | 2018 |
| Toward a better understanding of the physical stability of amorphous anti-inflammatory agents: the roles of molecular mobility and molecular interaction patterns M Rams-Baron, Z Wojnarowska, K Grzybowska, M Dulski, J Knapik, ... Molecular Pharmaceutics 12 (10), 3628-3638, 2015 | 38 | 2015 |
| Effect of polymer chain length on the physical stability of amorphous drug–polymer blends at ambient pressure J Pacułt, M Rams-Baron, B Chrząszcz, R Jachowicz, M Paluch Molecular pharmaceutics 15 (7), 2807-2815, 2018 | 36 | 2018 |
| Atorvastatin as a promising crystallization inhibitor of amorphous probucol: dielectric studies at ambient and elevated pressure J Knapik-Kowalczuk, Z Wojnarowska, M Rams-Baron, K Jurkiewicz, ... Molecular Pharmaceutics 14 (8), 2670-2680, 2017 | 36 | 2017 |
| Synthesis of new styrylquinoline cellular dyes, fluorescent properties, cellular localization and cytotoxic behavior M Rams-Baron, M Dulski, A Mrozek-Wilczkiewicz, M Korzec, W Cieslik, ... PLoS One 10 (6), e0131210, 2015 | 29 | 2015 |
| Distinguishing different classes of secondary relaxations from vapour deposited ultrastable glasses C Rodríguez-Tinoco, KL Ngai, M Rams-Baron, J Rodríguez-Viejo, ... Physical Chemistry Chemical Physics 20 (34), 21925-21933, 2018 | 27 | 2018 |
| How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions J Pacult, M Rams-Baron, K Chmiel, K Jurkiewicz, A Antosik, J Szafraniec, ... European Journal of Pharmaceutical Sciences 136, 104947, 2019 | 26 | 2019 |
| Secondary relaxation in ultrastable etoricoxib: evidence of correlation with structural relaxation C Rodríguez-Tinoco, M Rams-Baron, KL Ngai, K Jurkiewicz, ... Physical Chemistry Chemical Physics 20 (6), 3939-3945, 2018 | 23 | 2018 |
| Changes in physical stability of supercooled etoricoxib after compression M Rams-Baron, J Pacułt, A Jedrzejowska, J Knapik-Kowalczuk, M Paluch Molecular Pharmaceutics 15 (9), 3969-3978, 2018 | 22 | 2018 |
| Physical Instability: A Key Problem of Amorphous Drugs M Rams-Baron, R Jachowicz, E Boldyreva, D Zhou, W Jamroz, M Paluch, ... Amorphous Drugs: Benefits and Challenges, 107-157, 2018 | 22 | 2018 |
| Experimental evidence of high pressure decoupling between charge transport and structural dynamics in a protic ionic glass-former Z Wojnarowska, M Rams-Baron, J Knapik-Kowalczuk, A Połatyńska, ... Scientific Reports 7 (1), 7084, 2017 | 19 | 2017 |
| Iron chelators and exogenic photosensitizers. Synergy through oxidative stress gene expression A Mrozek-Wilczkiewicz, K Malarz, M Rams-Baron, M Serda, D Bauer, ... Journal of Cancer 8 (11), 1979, 2017 | 19 | 2017 |
| Current research trends in dielectric relaxation studies of amorphous pharmaceuticals: Physical stability, tautomerism, and the role of hydrogen bonding J Knapik-Kowalczuk, M Rams-Baron, M Paluch TrAC Trends in Analytical Chemistry 134, 116097, 2021 | 18 | 2021 |
| Electrophoretic deposition of chitosan coatings on the Ti15Mo biomedical alloy from a citric acid solution M Szklarska, B Łosiewicz, G Dercz, J Maszybrocka, M Rams-Baron, ... RSC advances 10 (23), 13386-13393, 2020 | 18 | 2020 |
| Can storage time improve the physical stability of amorphous pharmaceuticals with tautomerization ability exposed to compression? The case of a chloramphenicol drug J Knapik-Kowalczuk, Z Wojnarowska, K Chmiel, M Rams-Baron, L Tajber, ... Molecular Pharmaceutics 15 (5), 1928-1940, 2018 | 18 | 2018 |
| Amorphous protic ionic systems as promising active pharmaceutical ingredients: the case of the sumatriptan succinate drug Z Wojnarowska, J Knapik, M Rams-Baron, A Jedrzejowska, ... Molecular Pharmaceutics 13 (3), 1111-1122, 2016 | 17 | 2016 |
| Evidence of slow Debye-like relaxation in the anti-inflammatory agent etoricoxib M Rams-Baron, Z Wojnarowska, M Dulski, A Ratuszna, M Paluch Physical Review E 92 (2), 022309, 2015 | 17 | 2015 |
Marian PaluchProfessor of Physics, Institute of Physics and SMCEBI, University of SilesiaAdresse e-mail validée de us.edu.pl